UBS Group’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.07M | Sell |
|
|||||
|
2025
Q1 | $6.06M | Sell |
|
|||||
|
2024
Q4 | $8.1M | Buy |
|
|||||
|
2024
Q3 | $3.84M | Buy |
|
|||||
|
2024
Q2 | $1.67M | Sell |
|
|||||
|
2024
Q1 | $3.81M | Buy |
|
|||||
|
2023
Q4 | $1.43M | Buy |
|
|||||
|
2023
Q3 | $502K | Sell |
|
|||||
|
2023
Q2 | $2.09M | Buy |
|
|||||
|
2023
Q1 | $653K | Buy |
|
|||||
|
2022
Q4 | $483K | Buy |
|
|||||
|
2022
Q3 | $16K | Sell |
|
|||||
|
2022
Q2 | $66K | Sell |
|
|||||
|
2022
Q1 | $527K | Sell |
|
|||||
|
2021
Q4 | $986K | Buy |
|
|||||
|
2021
Q3 | $695K | Sell |
|
|||||
|
2021
Q2 | $781K | Buy |
|
|||||
|
2021
Q1 | $236K | Sell |
|
|||||
|
2020
Q4 | $467K | Sell |
|
|||||
|
2020
Q3 | $746K | Buy |
|